E. François

4.3k total citations · 1 hit paper
31 papers, 800 citations indexed

About

E. François is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. François has authored 31 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. François's work include Colorectal Cancer Treatments and Studies (5 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Soil Carbon and Nitrogen Dynamics (4 papers). E. François is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Soil Carbon and Nitrogen Dynamics (4 papers). E. François collaborates with scholars based in France, Belgium and United States. E. François's co-authors include Jean‐Luc Raoul, R. Sabot, Anne‐Marie Grolleau, Jean‐Yves Douillard, Laurent Bedenne, Olivier Bouché, G. Créhange, Marie‐Pierre Galais, Thierry Conroy and S. Gourgou-Bourgade and has published in prestigious journals such as PLoS ONE, The Lancet Oncology and Journal of Nutrition.

In The Last Decade

E. François

29 papers receiving 777 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

2014 276 citations Thierry Conroy, Marie‐Pierre Galais et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by E. François

Since Specialization

Citations

This map shows the geographic impact of E. François's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. François with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. François more than expected).

Fields of papers citing papers by E. François

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. François. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. François. The network helps show where E. François may publish in the future.

Co-authorship network of co-authors of E. François

This figure shows the co-authorship network connecting the top 25 collaborators of E. François. A scholar is included among the top collaborators of E. François based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. François. E. François is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy 2025 ·European Journal of Clinical Nutrition ·Marine Perrier, (unknown), Éric Bertin, (unknown), Damien Botsen, (unknown), E. François, Philippe Guilbert, (unknown), Florian Slimano, (unknown), Mathias Brügel, Olivier Bouché	1
2	Evolution of electrical, structural, and chemical properties of Li‐aluminosilicate glass during crystallization 2023 ·Journal of the American Ceramic Society ·M. Backhaus‐Ricoult, (unknown), E. François, (unknown), Bryan R. Wheaton	1
3	In-situ study of phase changes in glass by impedance spectroscopy and scaling 2023 ·Solid State Ionics ·M. Backhaus‐Ricoult, E. François	1
4	Dorsal Root Ganglion Stimulator for Chronic Pain: Early Experience 2023 ·Neuromodulation Technology at the Neural Interface ·Tanmoy Maiti, Reda Tolba, E. François, (unknown)	0
5	What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort 2021 ·Digestive and Liver Disease ·(unknown), L. Quéro, Emilie Barbier, (unknown), F. Juguet, P. Pommier, Louis Bazire, Isabelle Etienney, Nabil Baba-Hamed, (unknown), E. François, Philippe Ronchin, Eleonor Rivin del Campo, C. Lemanski, Astrid Lièvre, Laurent Siproudhis, Laurent Abramowitz, Côme Lepage, V. Vendrely	3
6	FOLFIRINOX in locally advanced (LA) and borderline resectable (BR) pancreatic adenocarcinoma: Update of the AGEO cohort 2019 ·Annals of Oncology ·Édouard Auclin, Lysiane Marthey, (unknown), E. François, António Sá Cunha, Jean‐Baptiste Bachet, David Tougeron, Angélique Vienot, Thierry Lecomte, Vincent Hautefeuille, J. Forestier, Michael Collins, (unknown), Romain Coriat, (unknown), (unknown), (unknown), Nicolas Williet, Julien Taı̈eb	1
7	Corrosion of mild steel at the seawater/sediments interface: Mechanisms and kinetics 2017 ·Corrosion Science ·Ph. Refait, Anne‐Marie Grolleau, Marc Jeannin, E. François, R. Sabot	48
8	Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX 2016 ·Oncology ·(unknown), Philippe Follana, Jocelyn Gal, Ludovic Evesque, (unknown), (unknown), E. François	18
9	Empirical and theoretical study of atelostomate (Echinoidea, Echinodermata) plate architecture: using graph analysis to reveal structural constraints 2015 ·Paleobiology ·Thomas Saucède, Rémi Laffont, (unknown), (unknown), E. François, Gunther J. Eble, Bruno David	10
10	Dorsal Root Ganglion (DRG) Stimulation in the Treatment of Phantom Limb Pain (PLP) 2015 ·Neuromodulation Technology at the Neural Interface ·Sam Eldabe, Katja Bürger, (unknown), (unknown), Stefan Schu, (unknown), (unknown), E. François, Jeffery Kramer, Jeyakumar Subbaroyan	78
11	FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients 2015 ·PLoS ONE ·Cindy Serdjebi, Johan Gagnière, Jérôme Desrame, Francine Fein, Rosine Guimbaud, E. François, Thierry André, Jean‐François Seitz, (unknown), Dominique Arsène, Julien Volet, (unknown), Thierry Lecomte, Véronique Guerin‐Meyer, Jean-Louis Legoux, G. Deplanque, Pierre Guillet, Joseph Ciccolini, Côme Lepage, Laëtitia Dahan	20
12	Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial breakdown → 2014 ·The Lancet Oncology ·Thierry Conroy, Marie‐Pierre Galais, Jean‐Luc Raoul, Olivier Bouché, S. Gourgou-Bourgade, Jean‐Yves Douillard, Pierre-Luc Etienne, Valérie Boige, Isabelle Martel‐Lafay, Pierre Michel, C. Llacer-Moscardo, E. François, G. Créhange, Méher Ben Abdelghani, Béata Juzyna, Laurent Bedenne, Antoine Adenis	276
13	BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer 2012 ·Annals of Oncology ·Anthony Gonçalvès, Marine Gilabert, E. François, Laëtitia Dahan, Hervé Perrier, R. Lamy, Daniel Ré, R. Largillier, Mohamed Gasmi, X. Tchiknavorian, Benjamin Esterni, Dominique Genre, (unknown), Marc Giovannini, J.F. Seitz, Jean‐Robert Delpéro, Olivıer Turrini, Patrice Viens, Jean‐Luc Raoul	176
14	Variations morphologiques des Toxaster (Echinoida : Spatangoida) en regard des fluctuations spatiales (Arc de Castellane, SE France) et temporelles (Valanginien-Hauterivien) du milieu sédimentaire : expression d'un potentiel adaptatif restreint 2006 ·Geobios ·E. François, Bruno David	4
15	Lésions prénéoplasiques et cancer du canal anal 2003 ·Bulletin du Cancer ·(unknown), E. François, Jean‐Pierre Gérard	3
16	Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients 2002 ·Annals of Oncology ·J. F. Seitz, Jaafar Bennouna, B Paillot, Érick Gamelin, E. François, Thierry Conroy, Jean‐Luc Raoul, Y. Bécouarn, F. Bertheault-Cvitkovic, Marc Ychou, S Nasca, A. Fandi, Philippe Barthélémy, Jean‐Yves Douillard	31
17	Fate of nitrogen fertilizer applied on two main arables crops, winter wheat (Triticum aestivum) and sugar beet (Beta vulgaris) in the loam region of Belgium 1993 ·Plant and Soil ·Jean-Pierre Destain, E. François, (unknown), Jean‐Pierre Goffart, (unknown), Bernard Bodson	7
18	[Occurrence of gastric phytobezoar after chemotherapy with vinorelbine]. 1993 ·PubMed ·(unknown), E. François, Michel Frenay, M Namer	1
19	EFFECTS OF DIFFERING METHODS OF CULTIVATION ON UPTAKE OF SOIL MINERAL NITROGEN AND SPLIT-APPLIED LABELED FERTILIZER NITROGEN BY WINTER WHEAT 1989 ·Soil Science ·Jean-Pierre Destain, Christian Roisin, (unknown), (unknown), (unknown), E. François	6
20	Copper in the Treatment of Molybdenosis in the Rat: Determination of the Dose of the Antidote 1965 ·Journal of Nutrition ·(unknown), A. Burny, (unknown), E. François, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact